MarginsXMarginsX
Home › Markets › Health Care › PMN

ProMIS Neurosciences Inc. Common Shares (ON) (PMN)

PMN trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$3.31
+0.61% on the day
Market cap
$29.8M
Nano cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerPMN on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryCanada
IPO yearNot reported by the screener
SEC CIK0001374339
SEC industry codePharmaceutical Preparations
Incorporated inCanada

Financials

Foreign filer: no machine-readable annual figure in SEC data.

Warning signs

Cash runway
12.8 months
$44.1M cash at September 30, 2026
Share count, 1 year
+318.0%
2025-11-12 to 2026-11-12 · +1091.0% over 3 years
Going-concern doubt
No
10-Q filed November 12, 2026
Insider net buying, 12 months
$257K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-12
Cash and burn$44.1M cash; operating cash flow -$10.4M a quarter.Report 2026-09-30
Shares outstanding8,996,862 (2026-11-12); 53,811,110 a year earlier; 18,885,254 three years earlier. 1y figure adjusted for splits (1-for-25 overall); 3y figure adjusted for splits (1-for-25 overall).Cover page 2026-11-12
Reverse splits, 3 years1; latest 1-for-25 on 2025-11-28Source 2025-11-28
Shelf and offerings, 12 months2 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-03-25
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorBaker Tilly US, LLP, Tewksbury, Massachusetts, United StatesPCAOB Form AP 2026-04-21
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $257K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
Not filed-$8.2M-$9.4M$44.1MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q2 2026
2026-06-30
Not filed-$11.7M-$10.4M$53.4MNo debt tagsNeeds four quarters10-Q 2026-08-13
Q1 2026
2026-03-31
Not filed-$8.2M-$12.4M$63.8MNo debt tagsNeeds four quarters10-Q 2026-05-12
Q4 2025
2025-12-31
Not filed-$10.7M-$9.3M$6.1MNo debt tagsNeeds four quarters10-K 2026-03-25
Q3 2025
2025-09-30
Not filed-$11.6M-$10.1M$15.4MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q2 2025
2025-06-30
Not filed-$10.1M-$3.9M$4.5MNo debt tagsNeeds four quarters10-Q 2026-08-13
Q1 2025
2025-03-31
Not filed-$7.3M-$4.9M$8.4MNo debt tagsNeeds four quarters10-Q 2026-05-12
Q4 2024
2024-12-31
Not filed-$238K-$8.7M$13.3MNo debt tagsNeeds four quarters10-K 2026-03-25

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-32026-03-25
Latest annual report10-K2026-03-25
Latest quarterly / interim10-Q2026-11-12
Latest current report8-K2026-11-12
Latest proxyDEFA14A2026-04-09

Source: SEC EDGAR submissions feed, 377 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-20.9%
1 month-62.0%
3 months-77.8%
Year to date-51.8%
1 year-66.3%
From 52-week high-86.7%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
NXTCNextCure Inc.$6.68+4.38%$30.6M
SCYXSCYNEXIS Inc.$2.91-9.35%$29.0M
BCTXBriaCell Therapeutics Corp. Common Shares$3.30-2.65%$28.8M
NSRXNasus Pharma Ltd.$2.66-7.32%$31.2M
NNVCNanoViricides Inc.$1.24+0.81%$31.7M
AARDAardvark Therapeutics Inc.$1.26-5.26%$27.6M
RMTIRockwell Medical Inc.$6.76-4.38%$26.9M
MIRAMIRA Pharmaceuticals Inc.$0.6310-4.38%$26.5M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier